<DOC>
	<DOCNO>NCT02678208</DOCNO>
	<brief_summary>Postpartum hemorrhage common cause maternal death across world , responsible 25 % maternal death annually . Although effective tool prevention treatment available , feasible practical use develop world many birth still occur home untrained birth attendant . primary postpartum hemorrhage excessive bleeding genital tract within 24 hour delivery fetus affect general condition . Postpartum hemorrhage responsible around 25 % maternal mortality worldwide , reach high 60 % country . Postpartum hemorrhage also cause long-term severe morbidity , approximately 12 % woman survive postpartum hemorrhagewill severe anemia . Tranexamic acid antifibrinolytic compound potent competitive inhibitor activation plasminogen plasmin . At much high concentration non-competitive inhibitor plasmin . The inhibitory effect tranexamic acid plasminogen activation urokinase report 6-100 time streptokinase 6-40 time great aminocaproic acid .</brief_summary>
	<brief_title>The Effect Tranexamic Acid Uterine Blood Flow After Vaginal Delivery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>pregnant woman ( 3742 week ) , spontaneous labor Women expect normal vaginal birth . woman live fetus . multiple gestation polyhydramnios macrocosmic baby grand multipara woman hypertensive disorder previous history postpartum hemorrhage abnormal placentation ( placenta previa placental abruption ) history uterine scarring ( include cesarean section ) history blood/liver/renal/heart disease .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>